Latest uncovered stories

An observational study of over 17,000 UK Biobank participants found that meeting the standard 150 minutes per week of moderate-to-vigorous physical activity was associated with only an 8-9% lower risk of cardiovascular events. Achieving a greater than 30% risk reduction required roughly 560 to 610 minutes weekly, or three to four times current guidelines, with lower-fitness individuals needing slightly more activity for equivalent benefits. Researchers suggest future guidelines could distinguish minimum protection from optimal levels and personalize targets by fitness.

Why uncovered:Covered by health specialists, ScienceDaily, The Guardian and BMJ press materials, with limited broader mainstream pickup beyond initial May 2026 reports.

A large longitudinal analysis of more than 11,000 U.S. youth in the Adolescent Brain Cognitive Development Study found that teens who began using cannabis showed restricted improvement over time in memory, attention, language, and processing speed compared with non-users. THC exposure was specifically associated with worse episodic memory trajectories. The findings, published in Neuropsychopharmacology, come from researchers at the University of California San Diego who combined self-reports with toxicological testing.

Why uncovered:Covered by UC San Diego, ScienceDaily, local outlets, and medical trade press such as Medscape, with limited national mainstream pickup.

Scientists at Nagoya University have shown that complement protein C3 produced inside tumors, rather than circulating in the blood, improves the effectiveness of immune checkpoint blockade therapy by limiting immunosuppressive myeloid cells. The findings, published in Nature Communications, were supported by mouse experiments and analysis of human lung cancer samples. Mimicking this local C3 effect restored treatment sensitivity in previously resistant tumors in mice.

Why uncovered:Covered by university releases and specialist science outlets like ScienceDaily and News-Medical, with limited mainstream media pickup.

A randomised controlled trial of nearly 4,000 New Zealand infants found no significant difference in rates of eczema or bronchiolitis between those given acetaminophen (paracetamol) and those given ibuprofen for fever or pain in the first year of life. Serious adverse events were rare and unrelated to either medication. The results, published in The Lancet Child & Adolescent Health, form the first-year findings of the ongoing PIPPA Tamariki study.

Why uncovered:Covered by ScienceDaily, university releases, and medical specialist outlets like MedicalXpress and MedPage Today, with limited pickup in major mainstream news organisations.

A prospective cohort study of over 1,000 rheumatoid arthritis patients in South Korea found that higher levels of fine particulate matter (PM2.5) are associated with increased disease activity and a greater likelihood of painful flares. Prolonged exposure exceeding two weeks showed the strongest links, according to findings published in the Annals of the Rheumatic Diseases. Researchers recommend that patients limit time outdoors during periods of poor air quality.

Why uncovered:Covered by specialist medical outlets, ScienceDaily, EurekAlert, and wire services like PTI, with limited pickup in major Western mainstream media.

The World Health Organization reported on 4 August 2026 that Phase 1 trials of the first vaccines specific to the Bundibugyo Ebola strain have begun in the UK and Canada, while a post-exposure prophylaxis trial is underway in DR Congo’s Ituri province. The outbreak, the largest ever recorded in the country, has caused 3,748 confirmed cases and 1,657 deaths as of 1 August. No licensed vaccines or specific treatments currently exist for this strain.

Why uncovered:Covered by UN News, Reuters and specialist health outlets, with limited broader mainstream pickup beyond general outbreak reports and worker pay protests.

A peer-reviewed study from the Weizmann Institute of Science shows that sildenafil, the active ingredient in Viagra, can impair cancer cells' ability to metastasize by trapping cholesterol in lysosomes. Laboratory models and analysis of health records from millions of patients indicated reduced spread and improved survival, especially when combined with statins. Researchers call for clinical trials to explore potential therapeutic use.

Why uncovered:Covered by Weizmann, Cancer Research, Times of Israel, Healthline, Newsweek and science sites, with limited major international mainstream pickup.

The European Centre for Disease Prevention and Control issued a risk assessment on 16 July 2026 documenting rising cases of ceftriaxone-resistant Neisseria gonorrhoeae across Europe since 2022, including evidence of local transmission in several countries. Overall risk remains low for the general population but higher for those with multiple partners or travel-linked exposures; all reported cases have been successfully treated so far. ECDC recommends strengthened surveillance, testing, and prevention measures to preserve treatment options.

Why uncovered:Covered by ECDC primaries, specialist outlets like Labmate Online and StudyFinds, plus some tabloids; limited pickup in major international wire and broadsheet mainstream media.

A 2025 Cell review by University of Copenhagen researchers describes how brain circuits evolved to defend body fat stores defend a previously higher weight after loss, increasing hunger and reducing energy use. This biological response, not simply willpower failure, helps explain common weight regain and the temporary effects of drugs like Wegovy. The findings, popularized in a The Conversation article, underscore obesity as a neurobiological condition with implications for treatment and prevention.

Why uncovered:Covered by The Conversation, ScienceDaily, Yahoo and select international outlets, with limited major mainstream pickup.

A Penn State-led ancillary analysis of a randomized trial found that adults with abdominal obesity who ate one avocado daily for six months reduced blood concentrations of LDL particles by about 49 nmol/L compared with those on their habitual diet. Researchers estimated this change corresponds to an approximate 4% lower heart disease risk, with no significant effects on weight or other lipoprotein measures.

Why uncovered:Covered by university releases, ScienceDaily, EurekAlert, MedicalXpress and some local TV, with limited national mainstream pickup.

Researchers at Houston Methodist have found that obesity elevates levels of phosphatidylethanolamines (PEs), fat molecules that travel to the brain, disrupt immune defenses, and promote amyloid buildup associated with Alzheimer's disease. Restoring PE balance in disease models improved cognitive function. The findings, published in Molecular Neurodegeneration, suggest a potential therapeutic target for metabolically at-risk individuals.

Why uncovered:Covered by institutional releases, ScienceDaily, EurekAlert, and specialist outlets like Drug Discovery News, with limited mainstream media pickup.

A secondary analysis of the large COSMOS randomized trial found that older adults taking a daily multivitamin for three years reported better functional health scores than those on placebo. The modest improvements, measured by a validated questionnaire on symptom burden and physical ability, were presented at the American Society for Nutrition’s NUTRITION 2026 meeting. Researchers noted the findings are preliminary pending peer-reviewed publication.

Why uncovered:Covered by ScienceDaily, EurekAlert, Newsweek, U.S. News/HealthDay and specialist sites, with limited pickup by major national newspapers or broadcasters.

The European Centre for Disease Prevention and Control (ECDC) said longer and warmer summers are increasing risks of foodborne illnesses, vibriosis, mosquito-borne diseases and tick-borne infections. The agency called for stronger cross-border and cross-sector cooperation under a One Health approach, noting that while many EU states have climate adaptation plans, dedicated public health measures for extreme weather need strengthening.

Why uncovered:Covered by ECDC primary release, Euronews, Brussels Times and specialist/local outlets, with limited broader mainstream pickup.

The European Centre for Disease Prevention and Control reports that while hepatitis B prevalence in young children has fallen to near-zero levels and vertical transmission is below 2%, uneven vaccination coverage and inadequate harm reduction mean the EU/EEA will miss 2030 elimination targets. An estimated five million people live with chronic hepatitis B or C, causing nearly 60,000 related deaths yearly. Only a minority of countries meet key WHO prevention benchmarks.

Why uncovered:Covered by ECDC primary release, EurekAlert, Medical Xpress and specialist outlets; limited pickup in major mainstream news organisations.

Scientists at MIT and the Broad Institute employed deep learning models to screen millions of compounds and discover a novel structural class of antibiotics effective against methicillin-resistant Staphylococcus aureus (MRSA). The compounds reduced bacterial levels in mouse models of infection while showing low toxicity to human cells. The approach also provided insights into the chemical substructures driving the activity.

Why uncovered:Covered by Nature, MIT News, Broad Institute, EurekAlert, and Scientific American, with limited general mainstream news pickup.

A team led by University of Vermont scientists has determined that black skin lesions common in brown bullhead catfish in Lake Memphremagog and nearby waters are a clonally transmissible melanoma. Whole-genome sequencing showed tumor cells from different fish share extensive genetic variants absent from their hosts, marking the first such cancer in fish or any freshwater species and only the fourth type known in animals. The findings, published in Nature, raise questions about transmission, origins, and ecological effects while confirming no risk to humans.

Why uncovered:Covered promptly by Nature, university releases, science sites, NYT, NPR and some outlets, yet limited sustained broader mainstream attention relative to biological novelty.

The European Medicines Agency's Committee for Medicinal Products for Human Use has recommended marketing authorisation for Icotyde (icotrokinra), the first oral medicine targeting the interleukin-23 receptor for moderate-to-severe plaque psoriasis, and Susvimo (ranibizumab), a refillable ocular implant for neovascular age-related macular degeneration. Both positive opinions from the July 2026 meeting now go to the European Commission for final decisions. These recommendations expand treatment options for two common chronic conditions affecting quality of life and vision.

Why uncovered:Covered by EMA primary releases and specialist pharma outlets like The Pharma Letter and company statements, with limited mainstream media pickup.

A University of Nottingham-led randomized trial found that a daily 20g prebiotic inulin supplement reduced knee pain in adults with osteoarthritis over six weeks, while also improving grip strength and lowering pain sensitivity. The INSPIRE study of 117 participants showed benefits comparable to digital physiotherapy for pain relief, with far higher retention rates, and linked effects to increases in gut-derived butyrate and GLP-1.

Why uncovered:Covered by ScienceDaily, university releases, HealthDay/US News and specialist outlets like Rheumatology Advisor, with limited major mainstream pickup.

A Cedars-Sinai analysis of nearly 355,000 UK Biobank participants followed for a median of 13 years found that greater coffee consumption was associated with reduced risks of cirrhosis, hepatocellular carcinoma and liver-related mortality. Benefits appeared with both caffeinated and decaffeinated coffee and were supported by MRI and proteomic data showing less liver fat, iron, fibrosis and inflammation. Researchers cautioned the findings are observational and do not prove causation.

Why uncovered:Covered by CNN, Washington Post, ScienceDaily and specialty GI outlets shortly after publication, with limited broader non-health-section pickup.

An international team led by Hiroshima University researchers has shown that the molecular organization and supramolecular chirality of dermal collagen begin to degrade before any thinning or fragmentation of collagen fibers becomes visible. Published in ACS Nano, the work used advanced optical and chiroptical imaging on human skin samples to reveal this early decoupling of collagen quantity from structural order. The findings could support earlier assessment of tissue integrity for aging research, wound healing, and biomaterial design.

Why uncovered:Covered by science press releases, ScienceDaily, Newsweek and specialist outlets, with limited broader mainstream news pickup.